This is a mock web-of-trust for an actual healthcare collective known as Ascendance Biomedical.
Systems like these will allow consumers to examine the supply chain, and make informed decisions based on verified reports from other entities.
By using mutually signed cryptographic transactions shaped by smart contract logic, participants can make claims about each other. Each node is a person or digital object, represented perhaps by an Ethereum address. Each connection is an attestation - a certification or rating.
Click on a node for additional entity information.
0: The research company verifies testers, to prevent falsified experimental data.
1: The science team proposes a therapy; methods and materials are posted publicly.
2: Biomedical company accepts (or declines) the proposal.
3: The therapy is sent by the science team to verified testers who begin their trial.
4: Testers give public feedback about the therapy, using permanent blockchain records.
5: The biomedical company certifies the therapy as legitimate if the trials are succesful.
6: After the therapy is certified by the research company, the 'owner' of the therapy (typically the science team) can certify manufacturers to produce the therapy.
7: Manufacturers can certify a distributor as a legitimate outlet.
8: Patients purchase from a distributor.
9: Patients can make a public review of distributor after their purchase.
10: Patients are able to lodge negative feedback on the research company, which pressures them to clean up the supply chain if a bad actor is present, or even revoke a therapy's certification if need be.
This is how certifications and ratings are used to shape the system.
Each large arrow is a certification,and each small arrow is a chance to get a rating after a transaction.
This is how cryptocurrency flows in the system.
Eventually, smart contracts can autonomously forward money up the chain whenever a purchase is made.
This is the actual web-of-trust that is being used in the first run through of this system.
The delivered therapy is a N6 plasmid therapy to combat HIV, in decentralist Tristan Roberts
Ascendance Biomedical's first therapy - Inovium Ovarian Rejuvenation - has already restored fertility to dozens of women. It is currently in Stage 1 testing in the USA.
Using plasmids, HIV+ individuals will be given the genetic instructions to create the N6 antibody. This antibody is produced in some humans and has been shown to be effective at destroying ~95% of HIV strains.
Using plasmids, instructions to create Follistatin are given. This is a well documented performance and longevity enhancing substance that inhibits myostatin. Myostatin is a protein that catabolizes (breaks down) muscle and other tissues. Follistatin treatments have been shown to significant increase muscle mass with no behavioral or dietary changes.
A new era of biomedicine is emerging, in which people have greater freedom and awareness in how they pursue personal healing and augmentation. The ideas presented on this page outline new modes of research and delivery that rely upon recent advances in cryptographic networks.
Decentralized marketplaces such as OpenBazaar facilitate the distribution of goods on at a global level. As these markets do not reside in a specific place, it is all but impossible for regulatory agencies to enforce their policies on either buyers or sellers. The risks and opportunities presented by these gray markets are immense: they have the opportunity to destroy life just as easily as preserve it. The potential hazards can be mitigated by applying cryptography, allowing the healing therapies to flourish.
A web-of-trust is a network in which entities vouch for the existence of each other by co-signing a transaction. These webs establish a transparent network of entities that allow entities to use pseudonyms, preserving their privacy. This simple concept can be expanded upon to create an entire supply chain that a potential customer is able to examine before making a purchase.
In the Ascendance model, a research company acts as a centralized, trusted authority. A science team proposes a experimental protocol to the research company, and the research company may authorize it by signing the proposal with their crypto-signature. Testers are able to acquire the therapy from the science team, and then attach a negative or positive attestation to the therapy. After sufficient data has been collected, the research company can approve the experimental therapy.
Once a therapy is approved, the originating science team is then able to issue certifications to manufacturers that carry the weight of the research company’s reputation. The manufacturers can then in turn certify distributors as being legitimate. A certified distributor is able to display their certification publicly on a decentralized marketplace such as OpenBazaar.
A potential customer is able to view the entire web-of-trust built upon this sequence of certifications from Ascendance’s website, or by using an Ethereum blockchain explorer. In addition to being able to verify that their distributor has been certified to provide the therapy, they can examine the negative and positive attestations on the therapy provided by the testers.
Any tester or patient that purchases a therapy is able to lodge negative attestations on their source of the therapy as well as the research company. These cryptographically signed ratings are public for future potential customers, and provides an incentive for all parts of the supply chain to push out any bad actors, who for instance, may peddle fake therapies. Entities that issue certifications can later void that certification when negative evidence accumulates.
The Ascendance system relies upon largely existent cryptographic technology to provide an alternative to the established biomedical industry. It is able to scale up rapidly while minimizing malevolent interference. This novel research and delivery paradigm permits humanity to move past the stagnation in biomedicine that has resulted from a confluence of maladaptive incentive structures; incentives that prioritize development of patentable therapies that treat symptoms rather than effective cures.
Placeholder for Roadmap
You may contact the designer of this system at aitheric at protonmail.com